IRCT201211179855N2
已完成
未知
Randomized, Double-Blind, Placebo-Controlled Trial of L-Arginine Supplementation for the treatment of pulmonary Tuberculosis
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Tuberculosis.
- 发起方
- Arak University of Medical Sciences
- 入组人数
- 60
- 状态
- 已完成
- 最后更新
- 8年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •adults over 15 years ;New cases of positive sputum smear
- •Exclusion criteria: pregnant women ; aged under 15 years, ;patients who During the past month received L\-arginine ; Sensitivity to L \- arginine
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Ferric Carboxymaltose Versus Placebo in Patients with Congestive Heart FailureEUCTR2012-001134-33-DEniversitätsklinikum Ulm
招募中
4 期
Randomized, Double-Blind, Placebo-Controlled Trial of 6 Months versus 12 Months Clopidogrel Therapy After Implantation Of A Drug-Eluting Stent Intracoronary Stenting and Antithrombotic Regimen:Safety And Efficacy of Six-Months Dual Antiplatelet Therapy After Drug-Eluting StentingI20I21I22I23I24I25Angina pectorisAcute myocardial infarctionSubsequent myocardial infarctionCertain current complications following acute myocardial infarctionOther acute ischaemic heart diseasesChronic ischaemic heart diseaseDRKS00000132Klinik für Herz-und KreislauferkrankungenDeutsches Herzzentrum München6,000
Enrolling By Invitation
4 期
Adjunctive vitamin d2 supplement in patient with allergen-specific immunotherapy randomized, double-blind, placebo-controlled trialPatients with allergic rhinitis and asthma begin treatment with allergen-specific immunotherapy.Calciferol, Vitamin D2 , allergic rhinitis, asthma, allergen-specific immunotherapy, TNSS score, ACT score, PEFR, Absolute eosinophilTCTR20190813001Phramongkutklao Medicine Foundation30
尚未招募
不适用
Project goal is eliminate HIV within all systems of the body and to prevent its transmission.HIV/AIDSTuberculosisMalariaupper respiratory tract infectionsPACTR201401000720267Health Gateway (PTY) Ltd200
进行中（未招募）
1 期
ATherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]Patients suffering from unilateral lateral epicondylitis, persistent for more than 3 months or recurrent and not having responded to at least one reference treatmentMedDRA version: 20.0 Level: PT Classification code 10014971 Term: Epicondylitis System Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2017-001709-33-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)150